Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × fluciclovine F-18 × Clear all

Phase

Phase 2 3 Phase EARLY_PHASE1 2 Phase 1 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Lymphoma, Follicular 1 Disease 1 Brain Neoplasms 1

Interventions

Radiosurgery 21 Radiotherapy 20 Temozolomide 16 Lomustine 9 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Methylphenidate 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Gefitinib 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 Carmustine 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04410133 2025-08-28

REVELATE

Blue Earth Diagnostics

Phase 3 Completed

151 enrolled 29 charts

Brain Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡